Ethics

conflicts and disclosures

Payments made to Adams from the pharmaceutical industry are disclosed publicly both on our website and on openpaymentsdata.cms.gov.

Regulatory Inspections

Adams is regulated by the Food and Drug Administration and the Massachusetts Department of Public Health and is subject to audits of its facility and records. Adams Clinical has had two Massachusetts DPH inspections and one federal FDA inspection, and all three resulted in no voluntary or official corrective action indicated.

confidentiality

Adams never permits pharmaceutical companies or their consultants to learn the identities of our anonymous trial participants unless requested to by the participant.

Hiring and Investment Restrictions

Employees and consultants to Adams are forbidden from having any investment in the pharmaceutical industry outside of index funds, and Adams does not hire employees with first-degree relatives who work in the pharmaceutical industry.

Bribery precautions

Employees and Consultants to Adams do not accept consulting fees, food, beverage, or lodging assistance from pharmaceutical companies, and any other payments from pharmaceutical companies unless the payments are directly tied to associated research work performed.

Reimbursed Physician Referrals

Adams may offer reimbursement to outside clinicians for their consultation time spent referring potential participants to clinical trials. If a clinician has been reimbursed by Adams Clinical, this relationship is always disclosed in writing to that clinician’s patient.